Therapies that target molecular pathways do not provide uniform benefits for all patients at present. New transformative therapies for autoimmune and inflammatory diseases require greater molecular understanding of patient subsets and the ability to personalize targeted therapies for each subset.
Andrew C Chan, Timothy W Behrens. Personalizing medicine for autoimmune and inflammatory diseases. Nature immunology. 2013 Feb;14(2):106-9
PMID: 23334822
View Full Text